MP53-13 USE OF ADJUVANT ANDROGEN DEPRIVATION THERAPY IN PRIMARY RADIATION THERAPY FOR PATIENTS >75 YEARS OLD WITH PROSTATE CANCER: ANALYSIS OF RTOG DATA | Zendy

AI Assistant Blog Pricing

MP53-13 USE OF ADJUVANT ANDROGEN DEPRIVATION THERAPY IN PRIMARY RADIATION THERAPY FOR PATIENTS >75 YEARS OLD WITH PROSTATE CANCER: ANALYSIS OF RTOG DATA

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.